Requirement For Producer Cell Line For GMP Viral Vector Packaging
What the buyer wrote
NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Requirement For Producer Cell Line For GMP Viral Vector Packaging
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Kind of work
- Health and social care
Who the buyer named
The buyer published a contact address on this notice.